Tag Archives: Forward Looking Statements Certain

Business, Finance, Occupation & Industry

Green Mountain Coffee Roasters, Inc. Announces Fiscal 2013 Second Quarter Reporting Date, Conference

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Green Mountain Coffee Roasters, Inc. Announces Fiscal 2013 Second Quarter Reporting Date, Conference Call and Live Webcast

WATERBURY, Vt.–(BUSINESS WIRE)– GreenMountain Coffee Roasters, Inc. (NAS: GMCR) , a leader in specialty coffee and coffee makers, today announced that the Company plans to announce financial results for its fiscal 2013 second quarter in a press release to be issued following the close of the financial markets on Wednesday, May 8, 2013.

In conjunction with this announcement, the Company will host a conference call with investors and analysts on Wednesday, May 8, 2013 at 5:00 p.m. ET. The live conference call will be simultaneously webcast and will be accessible from the events link in the Investor Relations portion of the Company’s website: http://investor.gmcr.com/events.cfm. The webcast will be archived for replay following the conclusion of the live event. Individuals who prefer not to use the internet for either the live call or the replay can call the Investor Services Department at GMCR, (802) 488-2559, to make alternate arrangements to hear the call by telephone live or the replay through Sunday, May 12, 2013.

About Green Mountain Coffee Roasters, Inc. (Nasdaq: GMCR)

As a leader in specialty coffee and coffee makers, Green Mountain Coffee Roasters, Inc. (GMCR) (NAS: GMCR) , is recognized for its award-winning coffees, innovative Keurig® single cup brewing technology, and socially responsible business practices. GMCR supports local and global communities by investing in sustainably-grown coffee, and donating a portion of its profits to social and environmental projects.

GMCR routinely posts information that may be of importance to investors in the Investor Relations section of its website, including news releases and its complete financial statements, as filed with the SEC. The Company encourages investors to consult this section of its website regularly for important information and news. Additionally, by subscribing to the Company’s automatic email news release delivery, individuals can receive news directly from GMCR as it is released.

Forward-Looking Statements

Certain information contained in this release, including statements concerning expected performance such as those relating to net sales, earnings, cost savings, acquisitions and brand marketing support, are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Generally, these statements may be identified by the use of words such as “may,” …read more

Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Senesco Provides Management Update

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Senesco Provides Management Update

BRIDGEWATER, N.J.–(BUSINESS WIRE)– Senesco Technologies, Inc. (“Senesco” or the “Company”) (OTC:SNTI) today announced that Leslie J. Browne, Ph.D., the Company’s President and Chief Executive Officer, is being treated for a medical condition that may limit his time to travel and attend public events. However, Dr. Browne will continue with his day-to-day duties and responsibilities as President and CEO of the Company. The Senesco Board has agreed to assist Dr. Browne with certain activities, including Harlan Waksal, M.D., Chairman of Senesco, who will take the lead on certain public activities like investor relations. The Board will continue to monitor Dr. Browne’s responsibilities as his treatment progresses.

Dr. Waksal stated, “Les has the full support of the Board as he manages the Company during this period of time, and we wish him a healthy recovery.”

In order to provide Dr. Browne and his family the privacy that they deserve, we will not be commenting further regarding Dr. Browne’s medical condition.

About Senesco Technologies, Inc.

Senesco, a leader in eIF5A technology, is sponsoring a clinical study to evaluate its lead therapeutic candidate SNS01-T in multiple myeloma, diffuse large B-cell lymphoma and mantle cell lymphoma. SNS01-T targets B-cell cancers and selectively induces apoptosis by modulating eukaryotic translation initiation factor 5A (eIF5A), which is believed to be an important regulator of cell growth and cell death. Accelerating apoptosis may have applications in treating cancer, while delaying apoptosis may have applications in treating certain inflammatory and ischemic diseases. Senesco has already partnered with leading-edge companies engaged in agricultural biotechnology and biofuels development, and is entitled to earn research and development milestones and royalties if its gene-regulating platform technology is incorporated into its partners’ commercialized products. Senesco routinely posts important information on the Company’s web site, www.senesco.com, and Senesco encourages investors to check the web site periodically for important updates.

Forward-Looking Statements

Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors, including, but not limited to: the Company’s ability to continue as a going concern; the Company’s ability to recruit patients for its clinical trial; the ability of the Company …read more

Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Annie's Appoints Isobel Jones as General Counsel and Secretary

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Annie’s Appoints Isobel Jones as General Counsel and Secretary

BERKELEY, Calif.–(BUSINESS WIRE)– Annie’s, Inc. (NYS: BNNY) , a leading natural and organic food company, today announced the appointment of Isobel Jones to the position of General Counsel and Secretary, effective April 1, 2013. Ms. Jones will serve as in-house legal counsel, managing legal and compliance matters and serving as a key member of Annie’s management team.

Ms. Jones will be based in the Company’s Berkeley headquarters and report directly to John Foraker, CEO of Annie’s.

“With extensive experience in compliance, governance and employment issues, as well as specific knowledge of the food industry, Isobel will be an ideal member of our executive team and we are excited to welcome her to Annie’s. The addition of Isobel to our senior management furthers our continued effort to position the Company to thrive as we continue to grow and expand,” said Mr. Foraker.

Prior to joining the Annie’s, Ms. Jones most recently served as Vice President, General Counsel and Corporate Secretary of Peet’s Coffee & Tea, Inc., where she provided legal advice, guidance and support on corporate governance, securities compliance, employment and labor matters, litigation, contracts, intellectual property, investor relations, and other matters. From June 2003 to January 2012, Ms. Jones was Associate General Counsel at Del Monte Foods, where she was responsible for SEC reporting and compliance, corporate governance matters, mergers and acquisitions, support of the treasury and investor relations functions and other general corporate matters. Ms. Jones also spent ten years as an associate at a national law firm. Ms. Jones earned her J.D. from Harvard Law School. She also holds an A.B. in East Asian Studies and Economics from Harvard University.

About Annie’s

Annie’s (NYS: BNNY) is a natural and organic food company that offers great-tasting products in large packaged food categories. Annie’s products are made without artificial flavors and synthetic colors and preservatives regularly used in many conventional packaged foods. Today, Annie’s offers over 125 products and is present in over 25,000 retail locations in the United States and Canada. Founded in 1989, Annie’s is committed to operating in a socially responsible and environmentally sustainable manner. For more information, visit www.annies.com.

Forward-Looking Statements

Certain statements in this press release, including statements regarding our continuing growth and expansion, are “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Ferro Announces Successful Amendment to Credit Facility

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Ferro Announces Successful Amendment to Credit Facility

Provides Greater Flexibility in Continued Execution of Value Creation Strategy

CLEVELAND–(BUSINESS WIRE)– Ferro Corporation (NYSE: FOE, the “Company”) today announced the amendment of its existing senior credit facility. The amendment reflects a further benefit achieved through the Company’s strategy to divest its solar pastes assets. The previously announced sale of Ferro’s solar pastes assets increased operating cash flows and significantly reduced the size of the Company’s precious metal consignment program and other working capital needs. As a result, Ferro is reducing the Company’s revolving loan commitment from $350 million to $250 million. The amendment will lower annual commitment fees by approximately $500,000 and modify certain financial and leverage ratio covenants. Additional details can be found in the Form 8-K that the Company will file with the Securities and Exchange Commission.

“Between cash on hand and expected cash from operations, we believe Ferro has sufficient cash resources to fully fund the initiatives now underway to reduce operating costs by over $50 million by the end of 2014,” said Peter Thomas, Interim President and Chief Executive Officer of Ferro. “By amending Ferro’s credit facility, very little of which currently has been utilized, we have gained significant additional financial flexibility to expand upon our cost savings programs and execute on other initiatives in our value creation strategy.”

The amendment was unanimously approved by the Company’s bank group.

About Ferro Corporation

Ferro Corporation (http://www.ferro.com) is a leading global supplier of technology-based performance materials for manufacturers. Ferro materials enhance the performance of products in a variety of end markets, including building and construction, automotive, appliances, electronics, household furnishings, pharmaceuticals, and industrial products. Headquartered in Mayfield Heights, Ohio, the Company has approximately 4,860 employees globally and reported 2012 sales of $1.8 billion.

Cautionary Note on Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of Federal securities laws. These statements are subject to a variety of uncertainties, unknown risks and other factors concerning the Company’s operations and business environment. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could adversely affect the Company’s future financial performance include the following:

…read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Nordion and Dr. Reddy's Laboratories Settle Claims

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Nordion and Dr. Reddy’s Laboratories Settle Claims

OTTAWA, Ontario–(BUSINESS WIRE)– Nordion Inc. (TSX: NDN) (NYS: NDZ) , a leading provider of products and services to the global health science market, has settled claims filed against Nordion by Dr. Reddy’s Laboratories Ltd. and certain affiliated companies (“Dr. Reddy’s”). Details of the settlement are confidential.

During fiscal 2009, Nordion was served with a Complaint from Dr. Reddy’s related to repeat study and mitigation costs of $10 million and lost profits of $70 million. This legal action, commenced by Dr. Reddy’s in New Jersey, related to certain bioequivalence studies carried out by the former MDS Pharma Services business unit from January 1, 2000 to December 31, 2004.

The settlement is expected to result in a loss of US$1.4 million for the Company after taking into account financial reserves maintained by the Company in relation to the claim. The settlement, most of which is covered by insurance, will result in a net cash outflow of US$17 million that includes insurance proceeds received to date. Nordion intends to report these items in its quarterly reporting for its second fiscal quarter of 2013.

About Nordion Inc.

Nordion Inc. (TSX: NDN) (NYS: NDZ) is a global health science company that provides market-leading products used for the prevention, diagnosis and treatment of disease. We are a leading provider of targeted therapies, sterilization technologies, and medical isotopes that benefit the lives of millions of people in more than 60 countries around the world. Our products are used daily by pharmaceutical and biotechnology companies, medical-device manufacturers, hospitals, clinics and research laboratories. Nordion has approximately 500 highly skilled employees worldwide. Find out more at www.nordion.com and follow us at http://twitter.com/NordionInc.

Forward-Looking Statements

Certain statements contained in this news release constitute “forward-looking statements”. These statements are based on current beliefs and assumptions of management, however are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from the forward-looking statements in this news release. For additional information with respect to certain of these beliefs, assumptions, risks and uncertainties, please refer to Nordion’s Annual Information Form for fiscal 2012 available on SEDAR at www.sedar.com and on EDGAR on www.sec.gov.

<div class="image …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Winland Electronics, Inc. Common Stock to Begin Trading on the OTCQB Market

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Winland Electronics, Inc. Common Stock to Begin Trading on the OTCQB Market

MANKATO, Minn.–(BUSINESS WIRE)– Winland Electronics, Inc. (NYSE Amex: WEX) today announced that its common stock will begin trading on the OTCQB Marketplace under the ticker symbol “WELX” commencing tomorrow, March 21, 2013. Investors will be able to view the Real Time Level II stock quotes for “WELX” at http://www.otcmarkets.com/stock/welx/quote.

The move to the OTCQB does not change Winland’s SEC reporting obligations under applicable securities laws. Accordingly, Winland will continue to file its Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K.


About OTC Markets Group Inc.


OTC Markets Group Inc. operates open, transparent and connected financial marketplaces for investors to easily trade almost 10,000 equity and debt securities through the broker of their choice. OTC Markets Group organizes these securities into tiered marketplaces to inform investors of opportunities and risks. OTC Markets Group’s data-driven platform enables efficient trading through any broker at the best possible prices and empowers a broad range of companies to improve the quality and availability of information for their investors.


About Winland Electronics


Winland Electronics, Inc. (www.winland.com), is an industry leader of critical condition monitoring devices. Products including EnviroAlert, WaterBug, TempAlert, Vehicle Alert and more are designed in-house to monitor critical conditions for industries including health/medical, grocery/food service, commercial/industrial, as well as agriculture and residential. Proudly made in the USA, Winland products are compatible with any hard wire or wireless alarm system and are available through distribution worldwide. Headquartered in Mankato, MN, Winland currently trades on the NYSE Amex Exchange under the symbol WEX but it will shortly be listed on the OTCQB Market under the symbol WELX.


Forward-Looking Statements


Certain of the matters set forth in this press release are forward-looking and involve a number of risks and uncertainties. These statements are based on management’s current expectations or beliefs. Actual results may vary materially from those expressed …read more
Source: FULL ARTICLE at DailyFinance